Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patients

Bastien Jamet 1, * Clément Bailly 1, 2 Thomas Carlier 1, 2 Lucie Planche 3 Cyrille Touzeau 4, 5 Françoise Kraeber-Bodéré 1, 6, 2 Philippe Moreau 4, 7 Caroline Bodet-Milin 1, 2
* Corresponding author
1 Département de Médecine Nucléaire [CHU Nantes]
2 CRCINA - Département NOHMAD - Equipe 13 - Oncologie nucléaire
CRCINA - Centre de recherche de Cancérologie et d'Immunologie / Nantes - Angers
3 PIMES - Département de Biostatistiques [CHU Nantes]
4 Département d'Hématologie [CHU Nantes]
5 CRCINA - Département NOHMAD - Equipe 10 - Regulation of Bcl2 and p53 networks in Multiple Myeloma and Mantle Cell Lymphoma
CRCINA - Centre de recherche de Cancérologie et d'Immunologie / Nantes - Angers
6 Département de Médecine Nucléaire [Saint Herblain]
7 CRCINA - Département NOHMAD - Equipe 11 - Integrative oncogenomics of multiple myeloma pathogenesis and progression
CRCINA - Centre de recherche de Cancérologie et d'Immunologie / Nantes - Angers
Abstract : no abstract.
Document type :
Journal articles
Complete list of metadatas

Cited literature [9 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-01823037
Contributor : Elizabeth Bernardo <>
Submitted on : Monday, June 25, 2018 - 4:31:53 PM
Last modification on : Monday, May 20, 2019 - 3:32:02 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

CNRS | UNIV-NANTES | CRCINA | UNIV-ANGERS

Citation

Bastien Jamet, Clément Bailly, Thomas Carlier, Lucie Planche, Cyrille Touzeau, et al.. Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patients. Leukemia & lymphoma, Taylor & Francis, 2019, 60 (1), pp.222-225. ⟨10.1080/10428194.2018.1459602⟩. ⟨inserm-01823037⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

139

Contact

Informations

CCSD